Elmiron®for women
Relief at the root.
Pentosan Polysulfate Sodium 100 mg — the only oral medication specifically approved for Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), a condition that affects women at up to 5-10 times the rate of men, now available and affordable across India.
Backed by 35+ years of global clinical evidence in women living with IC/BPS. 5 out of 7 randomised controlled trials confirmed efficacy. Prescribed by leading urologists and urogynaecologists across India.
How Elmiron® works for women
GAG Layer Restoration
In women with IC/BPS, the bladder's protective glycosaminoglycan (GAG) layer is often compromised. PPS is a synthetic polysaccharide and close analogue of this layer — it adheres to the urothelium, repairing the barrier that shields the bladder wall from urinary irritants.
Anti-inflammatory Action
Elmiron® inhibits mast cell histamine release and reduces submucosal inflammation, breaking the pain-inflammation cycle central to IC/BPS in women. Cystoscopic studies confirm reduction in mucosal redness, scarring, and hyperaemia.
Sustained Symptom Relief
Clinical benefit is duration-dependent, not dose-dependent. Women who responded showed improvement from 5–10 weeks, with benefit continuing to increase over 1–2 years. 80% of women who restarted therapy after stopping experienced rapid symptom return.
Two routes, one goal — relief for women with IC/BPS
Elmiron® Capsules
Pentosan Polysulfate Sodium
- Strength
- 100 mg
- Form
- Hard Gelatin Capsules
- Dose
- 100 mg three times daily
- Pack
- 30 / 90 Capsules
- Route
- Oral
Take on empty stomach, 1 hour before or 2 hours after meals.
Elmiron® Solution
Pentosan Polysulfate Sodium
- Strength
- 50 mg/mL
- Form
- Sterile Instillation Solution
- Volume
- 40 mL per instillation
- Pack
- 4 Vials
- Route
- Intravesical
Administered by a healthcare professional. Retain for a minimum of 30 minutes.
Approved & *emerging applications for women's bladder health
Interstitial Cystitis / BPS
Primary indication. A chronic bladder condition, disproportionately affecting women, causing pelvic pain, urgency, and frequency with no identifiable infection.
*Bladder Pain Syndrome
Suprapubic pain related to bladder filling, associated with at least one urinary symptom — common among women presenting with unresolved pelvic pain.
*Radiation Cystitis
Bladder inflammation following pelvic radiotherapy, including for gynaecological cancers. PPS aids mucosal repair and symptom relief.
*Hemorrhagic Cystitis
Hematuria and bladder irritation from chemotherapy agents. Intravesical PPS may help restore the protective barrier in affected women.
*Overactive Bladder (adjunct)
Used adjunctively in women with OAB who have co-existing urothelial dysfunction.
*Recurrent UTI Prevention
GAG layer restoration may reduce bacterial adherence and help prevent recurrent lower urinary tract infections, which women experience far more frequently than men.
India's best oral PPS therapy for women with IC/BPS
IC/BPS affects an estimated 3-8% of women in India, with many going undiagnosed or mismanaged for years as recurrent UTI. Elmiron® brings a PPS-focused therapy pathway to this missed clinical space for women.
As a pentosan polysulfate sodium formulation available in India, Elmiron® brings decades of global clinical evidence directly to Indian women living with IC/BPS.
Supported by the Missed Bladder Disease initiative, led by Dr. Sanjay Pandey, to close the diagnostic gap and improve recognition of IC/BPS in women across India.
Contact
For product enquiries, prescribing information, or medical information requests regarding Elmiron® for women with IC/BPS.